Barclays Cuts Xencor (NASDAQ:XNCR) Price Target to $6.00
Xencor (NASDAQ:XNCR – Free Report) had its price objective cut by Barclays from $22.00 to $6.00 in a report published on Thursday morning,Benzinga reports. They currently have an underweight rating on the biopharmaceutical company’s stock. XNCR has been the subject of several other research reports. Wells Fargo & Company lowered their target price on shares […]
Xencor (NASDAQ:XNCR – Free Report) had its price objective cut by Barclays from $22.00 to $6.00 in a report published on Thursday morning,Benzinga reports. They currently have an underweight rating on the biopharmaceutical company’s stock. XNCR has been the subject of several other research reports. Wells Fargo & Company lowered their target price on shares […]
